Enzo Biochem (ENZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
| 07-2023 | 07-2022 | 07-2021 | 07-2020 | 07-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 20,288 | -18,261 | 7,875 | -28,520 | 2,489 |
| Depreciation Amortization | 2,682 | 2,827 | 2,653 | 2,780 | 3,036 |
| Accounts receivable | 5,033 | -1,299 | -1,110 | 1,617 | 2,404 |
| Accounts payable and accrued liabilities | 1,159 | 390 | -395 | 1,214 | -2,508 |
| Other Working Capital | 18,558 | -6,835 | -4,774 | 7,957 | -3,006 |
| Other Operating Activity | -84,696 | 6,588 | -3,862 | -2,227 | 2,391 |
| Operating Cash Flow | $-36,976 | $-16,590 | $387 | $-17,179 | $4,806 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 28,695 | -30,061 | N/A | 0 |
| PPE Investments | -2,760 | -3,472 | -4,436 | -2,170 | -8,126 |
| Other Investing Activity | 101,740 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $98,980 | $25,223 | $-34,497 | $-2,170 | $-8,126 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 23,846 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | N/A | 7,412 | 4,500 |
| Debt Repayment | -4,136 | -269 | -339 | -411 | -404 |
| Common Stock Issued | 400 | 28 | 97 | N/A | 167 |
| Other Financing Activity | -21,235 | 0 | 0 | 0 | -70 |
| Financing Cash Flow | $-1,125 | $-241 | $-242 | $7,001 | $4,193 |
| Exchange Rate Effect | -109 | -63 | 11 | 67 | -18 |
| Beginning Cash Position | 22,603 | 14,274 | 48,615 | 60,896 | 60,041 |
| End Cash Position | 83,373 | 22,603 | 14,274 | 48,615 | 60,896 |
| Net Cash Flow | $60,770 | $8,329 | $-34,341 | $-12,281 | $855 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,976 | -16,590 | 387 | -17,179 | 4,806 |
| Capital Expenditure | -2,760 | -3,472 | -4,436 | -2,170 | -8,126 |
| Free Cash Flow | -39,736 | -20,062 | -4,049 | -19,349 | -3,320 |